Neo Ivy Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Neo Ivy Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,985	Closed	-$369K	–	518
2025 Q2	$369K	Buy	+19,985	New	+$355K	0.12%	233
2023 Q4	$41K	Buy	+2,856	New	+$40.6K	0.09%	182
2022 Q2	–	Sell	-23,246	Closed	-$346K	–	587
2022 Q1	$346K	Buy	23,246 +21,571	+1,288%	+$295K	0.31%	122
2021 Q4	$23K	Sell	1,675 -5,262	-76%	-$74.5K	0.03%	354
2021 Q3	$100K	Buy	+6,937	New	+$117K	0.11%	247
2021 Q2	–	Sell	-18,817	Closed	-$327K	–	592
2021 Q1	$327K	Buy	+18,817	New	+$331K	0.36%	96
2020 Q4	–	Sell	-2,202	Closed	-$30K	–	554
2020 Q3	$30K	Sell	2,202 -4,735	-68%	-$69.5K	0.03%	396
2020 Q2	$100K	Buy	6,937 +5,099	+277%	+$67K	0.11%	247
2020 Q1	$20K	Sell	1,838 -24,568	-93%	-$453K	0.03%	383
2019 Q4	$564K	Buy	+26,406	New	+$591K	0.65%	70
2019 Q1	–	Sell	-31,876	Closed	-$525K	–	387
2018 Q4	$525K	Buy	+31,876	New	+$642K	0.41%	108

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Neo Ivy Capital Management's SBRA Position: Q3 2025 in Review

Neo Ivy Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2025, closing a stake of 19,985 shares — an estimated $369K sold.

Neo Ivy Capital Management first reported a position in SBRA in Q4 2018 and held it in 11 quarters. The position peaked at $564K in Q4 2019. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.

Neo Ivy Capital Management reported no remaining Sabra Healthcare REIT position as of Q3 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 19,985 Sabra Healthcare REIT shares in Q3 2025, an estimated $369K.
Neo Ivy Capital Management first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 11 quarters.
Neo Ivy Capital Management's Sabra Healthcare REIT position peaked at $564K in Q4 2019.
424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.

Based on Neo Ivy Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.